Want to see SE:SLEEP full AI Analyst Report?
Sleep Cycle AB (SLEEP) AI Stock Analysis
Sleep Cycle AB
(Nasdaq OMX AB:SLEEP)
The score is held back primarily by weaker TTM profitability and a sharp deterioration in cash flow (negative free cash flow), despite a strong, low-leverage balance sheet. Technical momentum is supportive with the stock trading above key moving averages and a positive MACD, but valuation remains a headwind given the high P/E versus the recent operating reset.
Sleep Cycle AB (SLEEP) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 496.80M
- Dividend Yield
- 2.16%
- Average Volume (3M)
- 10.26K
- Price to Earnings (P/E)
- 41.5
- Beta (1Y)
- 0.04
- Revenue Growth
- -17.74%
- EPS Growth
- -79.85%
- Country
- Sweden
- Employees
- 39
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Application
Sleep Cycle AB Business Overview & Revenue Model
Company Description
Founded in 2001 and headquartered in Gothenburg, Sweden, Sleep Cycle AB (publ) specializes in providing applications for sleep monitoring. The company also engineers various devices designed to track both sleep and general health. Its flagship offeri...
How the Company Makes Money
Sleep Cycle AB primarily makes money through subscription revenue generated by its Sleep Cycle app. The company offers premium/paid plans that unlock advanced features (e.g., expanded analytics and insights, additional functionality and content), typ...
Sleep Cycle AB Financial Statement Overview
Summary
Mixed fundamentals: the balance sheet is strong with low leverage and solid equity, but TTM operating performance weakened (revenue decline and sharp margin compression) and cash generation deteriorated with free cash flow turning negative.
Income Statement
48NeutralBalance Sheet
78PositiveCash Flow
32Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 214.26M | 247.88M | 261.53M | 236.15M | 213.27M | 182.94M |
| Gross Profit | 32.72M | 121.36M | 201.87M | 128.55M | 156.65M | 141.62M |
| EBITDA | 20.90M | 73.62M | 88.45M | 74.26M | 48.23M | 12.37M |
| Net Income | 11.96M | 53.21M | 62.64M | 46.14M | 33.94M | 8.11M |
Balance Sheet | ||||||
| Total Assets | 179.50M | 200.15M | 236.49M | 230.54M | 301.37M | 227.76M |
| Cash, Cash Equivalents and Short-Term Investments | 75.17M | 120.85M | 144.82M | 133.47M | 232.86M | 165.51M |
| Total Debt | 5.01M | 7.38M | 11.74M | 15.92M | 4.20M | 2.49M |
| Total Liabilities | 117.83M | 128.31M | 157.04M | 169.55M | 140.54M | 118.86M |
| Stockholders Equity | 61.66M | 71.83M | 79.46M | 61.00M | 160.83M | 108.90M |
Cash Flow | ||||||
| Free Cash Flow | -6.78M | 52.88M | 59.73M | 51.00M | 53.76M | 14.15M |
| Operating Cash Flow | 12.85M | 52.93M | 63.66M | 52.72M | 61.53M | 20.09M |
| Investing Cash Flow | -38.43M | -13.15M | -3.92M | -6.81M | -7.77M | -5.93M |
| Financing Cash Flow | -13.89M | -64.19M | -48.36M | -145.30M | 14.01M | 98.22M |
Sleep Cycle AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SLEEP, the sentiment is Positive. The current price of 24.50 is above the 20-day moving average (MA) of 23.35, above the 50-day MA of 22.71, and above the 200-day MA of 21.39, indicating a bullish trend. The MACD of 0.60 indicates Negative momentum. The RSI at 63.60 is Neutral, neither overbought nor oversold. The STOCH value of 78.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:SLEEP.
Sleep Cycle AB Peers Comparison
Overall Rating
SE:TRUE.B72Outperform- SE:SLEEP56Neutral
SE:SEYE51Neutral
SE:BUSER43Neutral
SE:CFISH42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| SE:TRUE.B | 72Outperform | SEK 7.39B | 36.24 | 18.48% | 1.18% | -15.84% | -53.18% |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| SE:SLEEP | 56Neutral | SEK 496.80M | 41.48 | 17.62% | 2.16% | -17.74% | -79.85% |
| SE:SEYE | 51Neutral | SEK 2.10B | -15.69 | ― | ― | 35.21% | 40.30% |
| SE:BUSER | 43Neutral | SEK 158.53M | -1.66 | ― | ― | -19.34% | -1.24% |
| SE:CFISH | 42Neutral | SEK 157.44M | -7.22 | ― | ― | -47.90% | 36.77% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:SLEEP | Sleep Cycle AB | 24.50 | 1.12 | 4.77% | |
| SE:CFISH | Crunchfish AB | 1.90 | -1.46 | -43.45% | |
| SE:TRUE.B | Truecaller AB Class B | 23.82 | -3.92 | -14.12% | |
| SE:SEYE | Smart Eye AB | 53.50 | -29.50 | -35.54% | |
| SE:BUSER | Bambuser AB | 19.70 | 1.67 | 9.26% |
Sleep Cycle AB Corporate Events
Sleep Cycle’s Earnings Slump as New Owner Drives Strategic Overhaul
Sleep Cycle reported a sharp downturn in its third-quarter performance, with net sales falling 17.3% and a steep drop in EBITDA margin, driven partly by nearly SEK 14 million in non-recurring costs. Paying subscribers declined to 631,000 from 832,000...
Sleep Cycle to Webcast Q3 2026 Interim Report Presentation
Sleep Cycle AB will present its interim report for the third quarter of 2026 via a live webcast on October 23, with the report being published earlier the same morning on the company’s investor website. Acting CEO and CTO Mikael Kågebä...
Sleep Cycle to Acquire Audiowell in SEK 2.3 Billion Share Deal, Pivoting Deeper Into Wellness
Sleep Cycle AB has proposed acquiring all shares in Audiowell AB through a non-cash share issue valued at SEK 2,255 million, issuing over 92 million new shares at SEK 24.50 each at a premium to the latest closing price. The move deepens Sleep Cycle&#...
Sleep Cycle Calls EGM to Approve Audiowell Acquisition and Share Issue
Sleep Cycle AB has called an Extraordinary General Meeting for 11 November 2026 at its Gothenburg head office, giving shareholders the option to attend in person or vote by post, subject to registration and proxy rules set by Euroclear Nordics AB. Th...
Sleep Cycle to Replace Auditor After Ownership Change
Sleep Cycle AB has announced that its current auditor, Öhrlings PricewaterhouseCoopers AB, is resigning from its assignment before the end of its term due to changes in the company’s ownership structure that alter the nature of the engagem...
Sleep Cycle Reshapes Management Team as Product Chief Reclaims Key Role
Sleep Cycle AB has announced changes to its executive management team, as Chief Commercial Officer Peter Alsterberg will leave the company on 16 October 2026 after a handover period. Responsibility for partnerships is being moved to the product organ...
Sleep Cycle to Restructure Organisation for AI-Driven Efficiency and SEK 35 Million in Annual Savings
Sleep Cycle plans to streamline its organisation and adopt a more AI-driven way of working, reducing management layers and forming smaller decision-making teams led by experienced leaders. Around 15 positions will be affected and several consultancy...
Sleep Cycle’s Sleep Data Powers Global Study Linking Air Pollution to Nighttime Coughing
Sleep Cycle’s AI-driven sound technology has been used in a peer-reviewed study led by the University of Cambridge and Tsinghua University to explore links between air pollution and nighttime coughing in 32 cities across 12 countries. The app&#...
Sleep Cycle Fast-Tracks European Launch of AI Sleep Apnea Tool
Sleep Cycle AB, a leading sleep technology firm based in Gothenburg, is expanding beyond its roots as a consumer sleep app into a regulated medical platform. The company is focusing on AI-based sleep apnea risk detection, aiming to serve consumers, h...
Sleep Cycle Tech Built Into Moera Smart Mattress Toppers
Sleep Cycle has deepened its push into licensed sleep technology as partner Moera unveils temperature‑regulating mattress toppers powered by the Swedish company’s patented AI sound model. The new connected‑bedroom products embed Sle...
Sleep Cycle Study Shows App Cough Data Can Flag Flu and COVID‑19 a Week Early
Sleep Cycle has released findings from a three‑year research collaboration with the UK Health Security Agency showing that anonymized nocturnal cough data from its app can act as an early indicator of community respiratory illness. By comparing...
Sleep Cycle names tech chief Mikael Kågebäck acting CEO amid strategic review
Sleep Cycle AB has named Chief Technology and Product Officer Mikael Kågebäck as acting chief executive officer, effective 27 August 2026, following the departure of CEO Erik Jivmark. The leadership change comes shortly after Altor, via Sna...
Sleep Cycle’s Earnings Slide as Altor-Backed BidCo Takes Control and B2B Deals Grow
Sleep Cycle reported a sharp revenue decline and margin compression in the second quarter of 2026, with net sales down 21.5% and EBITDA turning negative amid falling subscriber numbers and costs related to extraordinary items. Despite weaker consumer...
Sleep Cycle to Webcast Second-Quarter 2026 Interim Report
Sleep Cycle AB will present its interim report for the second quarter of 2026 on 26 August via a public webcast aimed at shareholders, media and other stakeholders. The presentation, held in English by CEO Erik Jivmark and CFO & Head of IR Elisab...
Sleep Cycle installs new investor-aligned board in governance overhaul
Sleep Cycle AB has overhauled its governance structure at an Extraordinary General Meeting on 5 August 2026, confirming a five-member board without deputies and setting annual fees of SEK 500,000 for the chair and SEK 250,000 for each other director....
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 27, 2026